Glimilife-M2 Tablet PR
By Glimilife M
Rx
15 Tablet PR in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg)

Manufacturer - Lakshya Pharma Pvt Ltd
G-1, Sainnidhi Residency, Road No. 44C, Phanigiri Colony, Chaitanyapuri, Sainnidhi Residency, L. B. Nagar, Hyderabad-500060, Telangana, India

Expires on or after
October, 2025

liver
Glimilife-M2 Tablet PR should be used carefully by individuals with liver disease. Adjusting the dose of Glimilife-M2 Tablet PR may be necessary, so it's vital to seek advice from your healthcare provider. Typically, Glimilife-M2 Tablet PR is initiated at a low dosage for those with mild to moderate liver issues. However, it is advised to avoid using this medication in individuals with severe liver disease. If you have liver concerns, consult your doctor before using Glimilife-M2 Tablet PR.

kidney
Caution should be exercised with Glimilife-M2 Tablet PR in patients with kidney disease. Dose adjustment may be necessary, and it is advised to consult your doctor. Avoid use in severe kidney disease. Regular kidney function tests are recommended during treatment.

alcohol
It is not safe to drink alcohol while taking Glimilife-M2 Tablet PR.

driving
When taking Glimilife-M2 Tablet PR, avoid driving if you experience low or high blood sugar symptoms that can affect your ability to drive safely.

pregnancy
Glimilife-M2 Tablet PR may not be safe during pregnancy. Animal studies indicate potential harm to the developing baby. Consult your doctor, as they will assess the risks and benefits before prescribing this medication to you.

breastfeeding
Glimilife-M2 Tablet PR should be avoided during breastfeeding due to potential harm to the baby.
Habit Forming | No |
Chemical Class | Biguanide |
Therapeutic Class | ANTI DIABETIC |
Action Class | Sulfonylureas (Insulin Secretogogues) |
₹182.34
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024